JCM
BDSX icon

Jacobi Capital Management’s Biodesix BDSX Stock Holding History

Jacobi Capital Management’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-38
Closed -$6K – 505
2021
Q3 		$6K Hold
38
– – ﹤0.01% 1155
2021
Q2 		$10K Hold
38
– – ﹤0.01% 1022
2021
Q1 		$15K Buy
+38
New +$17K ﹤0.01% 847

Other funds holding BDSX

BC
Birchview Capital Burlington, Vermont $176M AUM 95.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Jacobi Capital Management's BDSX Position: Q4 2021 in Review

Jacobi Capital Management sold out of Biodesix (BDSX) in Q4 2021, closing a stake of 38 shares — an estimated $6K sold.

Jacobi Capital Management first reported a position in BDSX in Q1 2021 and held it in 3 quarters. The position peaked at $15K in Q1 2021. 41 funds tracked by Wall St. Rank hold BDSX as of Q4 2021.

  • Jacobi Capital Management reported no remaining Biodesix position as of Q4 2021 after selling out during the quarter.
  • Jacobi Capital Management sold 38 Biodesix shares in Q4 2021, an estimated $6K.
  • Jacobi Capital Management first reported a position in Biodesix in Q1 2021 and held it in 3 quarters.
  • Jacobi Capital Management's Biodesix position peaked at $15K in Q1 2021.
  • 41 funds tracked by Wall St. Rank held Biodesix as of Q4 2021.

Based on Jacobi Capital Management's 13F filing for Q4 2021, filed 14 Feb 2022.